全球大分子生物分析技術市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計大型分子生物分析技術的市場規模將從 2025 年的 108.4 億美元成長到 2034 年的 272.3 億美元，2026 年至 2034 年的複合年成長率為 10.77%。

由於生物製藥和生物相似藥的快速發展，全球聚合物生物分析技術市場正經歷快速成長。生物分析技術對於分析蛋白質和單株抗體等複雜分子至關重要。生物技術研發投入的增加和臨床試驗的擴展正在推動市場需求。製藥公司依賴先進的分析工具來確保藥物的安全性和有效性。

質譜和免疫檢測技術的進步是推動市場成長要素。精準醫療和個人化治療需求的不斷成長也促進了市場擴張。監管機構對全面生物製藥檢測的要求正在加速先進生物分析解決方案的應用。此外，外包給受託研究機構的增加也促進了市場成長。

隨著全球生物製劑開發平臺的不斷擴展，未來前景依然光明。新興市場對生物製藥生產的投資正在創造新的機會。各公司正致力於開發高通量、高靈敏度的分析平台。隨著生物製藥療法的重要性日益凸顯，全球大分子生物分析技術市場預計將持續成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球大分子生物分析技術市場：依產品分類

• 市場分析、洞察與預測
• 產品類別（耗材及配件、設備、試劑及試劑盒）
• 服務

第5章 全球大分子生物分析技術市場：依應用分類

• 市場分析、洞察與預測
• 生物製劑
• 寡核苷酸衍生的藥物和分子
• 病毒載體
• 細胞和基因治療
• 奈米顆粒和聚合物

第6章 全球大分子生物分析技術市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第7章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第8章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Intertek Group Plc
  • Solvias AG
  • Bio-Techne Corporation
  • Waters Corporation
  • Cytiva（A Danaher Company）
  • Verder Scientific GmbH & Co. KG
  • Halo Labs
  • Charles River Laboratories International Inc
  • Avomeen Analytical Services
  • Merck KGaA
  • Cergentis BV
  • Labcorp
  • SCIEX（A Danaher Company）
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc

The Large Molecule Bioanalytical Technologies Market size is expected to reach USD 27.23 Billion in 2034 from USD 10.84 Billion (2025) growing at a CAGR of 10.77% during 2026-2034.

The Global Large Molecule Bioanalytical Technologies Market is experiencing rapid growth due to increasing development of biologics and biosimilars. Bioanalytical technologies are essential for analyzing complex molecules such as proteins and monoclonal antibodies. Rising investments in biotechnology research and expanding clinical trials are driving demand. Pharmaceutical companies rely on advanced analytical tools to ensure safety and efficacy.

Major growth drivers include advancements in mass spectrometry and immunoassay techniques. Growing demand for precision medicine and personalized therapies is supporting market expansion. Regulatory requirements for comprehensive biologics testing are encouraging adoption of advanced bioanalytical solutions. Additionally, increasing outsourcing to contract research organizations is contributing to market growth.

Future prospects remain promising as biologics pipelines continue to expand globally. Emerging markets investing in biopharmaceutical manufacturing will create new opportunities. Companies are focusing on high-throughput and sensitive analytical platforms. As biologic therapies gain prominence, the Global Large Molecule Bioanalytical Technologies Market is expected to witness sustained growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• product (Consumables & Accessories, Instruments. Reagents & Kits)
• Service

By Application

• Biologics
• Oligonucleotide Derived Drugs & Molecules
• Viral Vector
• Cell & Gene Therapy
• Nanoparticles & Polymers

COMPANIES PROFILED

• Intertek Group plc, Solvias AG, BioTechne Corporation, Waters Corporation, Cytiva a Danaher company, Verder Scientific GmbH Co KG, Halo Labs, Charles River Laboratories International Inc, Avomeen Analytical Services, Merck KGaA, Cergentis BV, Labcorp, SCIEX a Danaher company, F HoffmannLa Roche Ltd, BioRad Laboratories Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL LARGE MOLECULE BIOANALYTICAL TECHNOLOGIES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. product (Consumables & Accessories, Instruments. Reagents & Kits) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Service Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL LARGE MOLECULE BIOANALYTICAL TECHNOLOGIES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Biologics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Oligonucleotide Derived Drugs & Molecules Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Viral Vector Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Cell & Gene Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Nanoparticles & Polymers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL LARGE MOLECULE BIOANALYTICAL TECHNOLOGIES MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product
  • 6.2.2 By Application
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product
  • 6.3.2 By Application
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product
  • 6.4.2 By Application
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product
  • 6.5.2 By Application
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product
  • 6.6.2 By Application
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL LARGE MOLECULE BIOANALYTICAL TECHNOLOGIES INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Intertek Group Plc
  • 8.2.2 Solvias AG
  • 8.2.3 Bio-Techne Corporation
  • 8.2.4 Waters Corporation
  • 8.2.5 Cytiva (A Danaher Company)
  • 8.2.6 Verder Scientific GmbH & Co. KG
  • 8.2.7 Halo Labs
  • 8.2.8 Charles River Laboratories International Inc
  • 8.2.9 Avomeen Analytical Services
  • 8.2.10 Merck KGaA
  • 8.2.11 Cergentis B.V
  • 8.2.12 Labcorp
  • 8.2.13 SCIEX (A Danaher Company)
  • 8.2.14 F. Hoffmann-La Roche Ltd
  • 8.2.15 Bio-Rad Laboratories Inc